KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Interest & Investment Income: 2009-2024

Historic Interest & Investment Income for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Dec 2024 value amounting to $25.5 million.

  • Acadia Pharmaceuticals' Interest & Investment Income rose 25.20% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.4 million, marking a year-over-year increase of 30.97%. This contributed to the annual value of $25.5 million for FY2024, which is 47.72% up from last year.
  • Acadia Pharmaceuticals' Interest & Investment Income amounted to $25.5 million in FY2024, which was up 47.72% from $17.2 million recorded in FY2023.
  • In the past 5 years, Acadia Pharmaceuticals' Interest & Investment Income registered a high of $25.5 million during FY2024, and its lowest value of $591,000 during FY2021.
  • Moreover, its 3-year median value for Interest & Investment Income was $17.2 million (2023), whereas its average is $16.4 million.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Interest & Investment Income tumbled by 91.06% in 2021 and then skyrocketed by 1,018.44% in 2022.
  • Acadia Pharmaceuticals' Interest & Investment Income (Yearly) stood at $6.6 million in 2020, then slumped by 91.06% to $591,000 in 2021, then spiked by 1,018.44% to $6.6 million in 2022, then surged by 160.73% to $17.2 million in 2023, then spiked by 47.72% to $25.5 million in 2024.